Research programme: growth factor modulators - Scholar RockAlternative Names: Niche modulators - Scholar Rock; SRK 015
Latest Information Update: 21 Oct 2014
At a glance
- Originator Scholar Rock
- Mechanism of Action Myostatin inhibitors; TGF-beta superfamily protein inhibitors; TGF-beta superfamily protein-modulators
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Autoimmune disorders; Fibrosis; Musculoskeletal disorders
Most Recent Events
- 15 Sep 2014 Preclinical trials in Musculoskeletal disorders in USA (unspecified route)
- 15 Sep 2014 Preclinical trials in Fibrosis in USA (unspecified route)
- 15 Sep 2014 Preclinical trials in Autoimmune disorders in USA (unspecified route)